Viewing Study NCT01686009



Ignite Creation Date: 2024-05-06 @ 12:53 AM
Last Modification Date: 2024-10-26 @ 10:56 AM
Study NCT ID: NCT01686009
Status: COMPLETED
Last Update Posted: 2013-02-05
First Post: 2012-09-12

Brief Title: Intra-nasal Ketamine for Analgesia in the Emergency Department
Sponsor: Lions Gate Hospital
Organization: Lions Gate Hospital

Study Overview

Official Title: Intra-nasal Ketamine for Analgesia in the Emergency Department
Status: COMPLETED
Status Verified Date: 2013-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: INKA
Brief Summary: The provision of analgesia to patients in pain is a fundamental necessity of emergency department practice and is usually accomplished using IV opioids However significant barriers exist to the provision of timely analgesia by the IV route

The use of the IN route for medication delivery provides an efficient and relatively painless mode of analgesia delivery As well ketamine is well-known to be an effective analgesic and to preserve cardiorespiratory function thus removing the necessity of physiologic monitoring that is obligatory when using opioids The use of ketamine by the IN route provides a rapid easy-administered and well-tolerated method for providing analgesia in the ED setting
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None